Immunoassay bioanalysis service by LGC – DDS

LGC's capabilities and experience cover recombinant proteins, vaccines, blood products, monoclonal antibodies, oligonucleotides, gene therapy products and more. Development and validation of bioanalytical assays to support your biopharmaceutical development programme, whether it be Pharmacokinetic (PK), Anti-Drug-Antibody (ADA), Neutralising Antibodies (nAbs) or Pharmacodynamic (PD) is core to the LGC business. 

LGC's bioanalytical services for biopharmaceuticals include: 

• New method development Method validation (GLP, GCP or non-regulated) 
• Sample analysis to support discovery, preclinical and clinical programmes
• Macromolecule quantification and characterisation to support biopharmaceutical development and manufacture
• Experienced, qualified staff and investment in the latest technologies allow us to provide high quality bioanalytical services for biopharmaceuticals in support of all stages of your development